Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Company

Ending Tuberculosis is Good Business

Today's Top Reads Close

Did you know that Tuberculosis (TB) is the world’s deadliest infectious disease, killing more people in 2018 than HIV and malaria deaths combined? Learn how Johnson & Johnson and its partners are working to help eliminate TB by 2030 through a new workplace initiative aimed at raising awareness and increasing access to prevention, screening, diagnosis, treatment and care at the 2020 World Economic Forum Annual Meeting. Together, this initiative will potentially improve the health of hundreds of millions of lives.

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue